Post-approval studies (Phase 4)Study completedNCT01358825
What this trial is testing
Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™
Who this might be right for
TetanusPoliomyelitisHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 58